Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Myocardial Reperfusion Injury in STEMI
NCT05734612Phase 3Unknown
- Sponsor
- Universitas Indonesia
- Start
- Dec 2022
- Primary completion
- Mar 2023
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in myocardial reperfusion injury, sponsored by Universitas Indonesia. Status: unknown.
02
Drugs
colchicine
03
Conditions
myocardial reperfusion injury
Beyond the preview
Go deeper on NCT05734612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05734612.